{
  "id": "4773ab37d4d64f54",
  "title": "Alphamab Oncology Announces the Results of a Phase III Clinical Study of Anbenitamab ( KN026 ) were Published in Annals of Oncology",
  "description": "20260127T033000Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2026/01/27/tmt-newswire/pr-newswire/alphamab-oncology-announces-the-results-of-a-phase-iii-clinical-study-of-anbenitamab-kn026-were-published-in-annals-of-oncology/2265636",
  "published_at": "20260127T033000Z",
  "fetched_at": "2026-01-28T00:24:25.269376+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2026/01/27/tmt-newswire/pr-newswire/alphamab-oncology-announces-the-results-of-a-phase-iii-clinical-study-of-anbenitamab-kn026-were-published-in-annals-of-oncology/2265636",
    "url_mobile": "https://www.manilatimes.net/2026/01/27/tmt-newswire/pr-newswire/alphamab-oncology-announces-the-results-of-a-phase-iii-clinical-study-of-anbenitamab-kn026-were-published-in-annals-of-oncology/2265636/amp",
    "title": "Alphamab Oncology Announces the Results of a Phase III Clinical Study of Anbenitamab ( KN026 ) were Published in Annals of Oncology",
    "seendate": "20260127T033000Z",
    "socialimage": "https://www.manilatimes.net/theme_manilatimes/images/TMT_1920x1008.jpg",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}